Physician profile
Hal T Liddell
NPI 1023032497
$6,568.62
in general payments reported to CMS, 2019-2025
55 companies · $826 in 2025
The $826 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,915 · 2020: $560 · 2021: $931 · 2022: $669 · 2023: $843 · 2024: $824 · 2025: $826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,493.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $930.99 | 2019 | |
| Astellas Pharma US INC | $734.55 | 2019-2025 | Xtandi |
| Janssen Biotech, INC. | $620.80 | 2019-2025 | Erleada |
| Allergan, INC. | $515.05 | 2019-2022 | |
| Abbvie INC. | $508.35 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $426.19 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $425.15 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $399.25 | 2019-2025 | |
| Coloplast Corp | $216.91 | 2019-2025 | Titan |
| C. R. Bard, INC. & Subsidiaries | $156.40 | 2021 | |
| Urogen Pharma, INC. | $144.20 | 2021-2025 | Jelmyto |
| Ethicon US, LLC | $138.83 | 2019-2024 | Echelon Flex, Certus 140 |
| Tolmar Pharmaceuticals, INC. | $118.80 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $72.67 | 2019-2024 | Provenge |
| Laborie Medical Technologies Corp. | $69.07 | 2023-2025 |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $67.42 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Progenics Pharmaceuticals, INC. | $52.52 | 2022-2024 | |
| Mission Pharmacal Company | $50.32 | 2021-2024 | Uribel Tabs, Uribel |
| Accord Healthcare, INC. | $50.00 | 2025 | |
| Tolmar, INC. | $46.46 | 2023-2024 | |
| Endo Pharmaceuticals INC. | $45.41 | 2019-2023 | Xiaflex, Aveed |
| Boston Scientific Corporation | $43.67 | 2022-2025 | Axonics |
| Acera Surgical, INC. | $40.82 | 2024 | Restrata Wound Matrix |
| Antares Pharma, INC. | $39.59 | 2019 | |
| Ferring Pharmaceuticals INC. | $36.85 | 2025 | Adstiladrin |
| Blue Earth Diagnostics | $34.08 | 2020-2023 | |
| Intuitive Surgical, INC. | $32.31 | 2020 | |
| Kerecis Limited | $31.69 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Urovant Sciences INC | $30.51 | 2022 | |
| Axonics, INC. | $29.57 | 2020-2021 | |
| Travere Therapeutics, INC. | $27.99 | 2019-2020 | |
| Tempus Ai, INC | $27.88 | 2024 | |
| Medtronic USA, INC. | $24.80 | 2019 | |
| Baxter Healthcare | $24.51 | 2020 | |
| Procept Biorobotics Corporation | $24.25 | 2025 | |
| Myovant Sciences INC. | $23.07 | 2021 | |
| Integra Lifesciences Corporation | $22.20 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Teleflex LLC | $20.45 | 2025 | Urolift |
| Reprise Biomedical, INC. | $19.98 | 2025 | Miro3d |
| Helsinn Therapeutics (U.S.), INC. | $19.71 | 2022 | |
| Verity Pharmaceuticals INC. | $18.19 | 2023 | Trelstar |
| E.R. Squibb & Sons, L.L.C. | $18.08 | 2022 | |
| Civco Medical Instruments | $17.84 | 2024 | |
| Standard Bariatrics, INC. | $17.65 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.05 | 2025 | Iovera, Exparel |
| Myriad Genetic Laboratories, INC. | $16.94 | 2021 | |
| Endo USA, INC. | $16.68 | 2025 | Xiaflex, Aveed |
| Takeda Pharmaceuticals U.S.A., INC. | $15.49 | 2021 | |
| Smith+Nephew, INC. | $14.86 | 2019 | |
| Alnylam Pharmaceuticals INC. | $13.98 | 2023 | Oxlumo |
| Medtronic, INC. | $13.82 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $13.49 | 2020 | |
| Shire North American Group INC | $13.30 | 2019 | |
| Rochester Medical Corporation | $11.34 | 2020 | |
| Ambu INC. | $6.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hal Liddell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.